Mylan Faces Criticism from BMO After FDA Warning Letter to Agila
October 18, 2013 at 16:10 PM EDT
Mylan, Inc. (NASDAQ: MYL ) shares took a 3+% hit today after BMO analyst David Maris commented that the FDA warning letter may issue an import ban on Agila products. On September 9th, the FDA sent a warning letter to Mylan regarding the use of non-sterile gloves for aseptic
